Plan B One-Step Goes OTC, With Three-Year Exclusivity, Lower Age Limit

FDA approved Plan B One-Step to be sold in some OTC venues to women 15 and older, lowering the age restriction and moving the product out from behind pharmacy counters. Teva Women’s Health gets three years of exclusivity for the product, based on studies of label comprehension among women as young as 15.

Teva Women's Health Inc. gains three years of OTC market exclusivity for Plan B One-Step with FDA’s April 30 approval of the firm’s proposal to make the product available to consumers 15 and older, in a qualified form of OTC sale.

Plan B One-Step (levonorgestrel 1.5 mg), the second generation of the original two-dose Plan B (levonorgestrel 0

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Rx-to-OTC Switch

More from Health